Combination therapy targeting Erk1/2 and CDK4/6i in relapsed refractory multiple myeloma

by Abiatari, I., Adamia, S., Anderson, K.C, Bhatt, S., Chyra, Z., Dorfman, D.M, Fell, G.G, Hideshima, T., Letai, A., Pioso, M.S, Tai, Y.-T, Wen, K.
Published 2022

Mutation landscape of multiple myeloma measurable residual disease: Identification of targets for precision medicine

by Bago, J.R, Bezdéková, R., Broskevičova, L., Černá, L., Chyra, Z., Fanfani, V., Filipová, J., Growková, K., Hájek, R., Harvanová, Ĺ, Hrdinka, M., Jelínek, T., Jungova, A., Kryukov, F., Maisnar, V., Minaŕík, J., Popková, T., Pour, L., Říhová, L., Ševčíková, T., Šimíček, M., Sithara, A.A, Smejkalová, J., Stracquadanio, G., Zátopková, M., Žihala, D.
Published 2022